Skip to search formSkip to main contentSkip to account menu

cosaldon

Known as: Cosadon 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
[Therapy of degenerative maculopathy with Cosaldon A + E].
Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative… 
1982
1982
[Influence of a Pentifylline-Nicotinic Acid Combination on Vigilance and Mental Performance (author's transl)].
The effect of a single dose of 4 sugar-coated tablets of Cosaldon (1-hexyl-3,7-dimethylxanthine (pentifylline) + nicotinic acid… 
1972
1972
Cosaldon for vascular disorders?
Cosaldon is a combined preparation which contains 50 mg nicotinic acid and 200 mg 1-hexyl-3, 7-dimethylxanthine in each tablet… 
1971
1971
The treatment of impending vascular occlusion with rheomacrodex, heparin and complamine.
  • A. Leeman
  • Ophthalmologica. Journal international d…
  • 1971
  • Corpus ID: 3355672
Author’s address: Dr. A. M. Leeman, van Hogendorplaan 1, Amersfoort (The Netherlands) I wish to demonstrate two cases in which… 
1969
1969
[Experiences with new Cosaldon forms].
  • C. Dammann
  • Medizinische Klinik
  • 1969
  • Corpus ID: 42530932
1963
1963
The value of cosaldon in cerebral arteriosclerosis.
1962
1962
[Improvement of brain circulation with cosaldon as a therapeutic measure in pediatrics].
1960
1960
[Treatment of cerebral arteriosclerosis with cosaldon].
1959
1959
[On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
1957
1957
[Cerebral sclerosis and its treatment with cosaldon].
  • J. Meyer
  • Medizinische Klinik
  • 1957
  • Corpus ID: 38616836